Table of Contents

February 1, 2023; Volume 64,Issue 2

  1. Bailly, Matthieu

    1. Precision of Myocardial Blood Flow and Flow Reserve Measurement During CZT SPECT Perfusion Imaging Processing: Intra- and Interobserver Variability
      Open Access
      Precision of Myocardial Blood Flow and Flow Reserve Measurement During CZT SPECT Perfusion Imaging Processing: Intra- and Interobserver Variability
      Matthieu Bailly, Frédérique Thibault, Gilles Metrard, Maxime Courtehoux, Denis Angoulvant and Maria Joao Ribeiro
      Journal of Nuclear Medicine February 1, 2023, 64 (2) 260-265; DOI: https://doi.org/10.2967/jnumed.122.264454

  2. Bajpai, Surabhi

    1. Application of the Lugano Classification for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The PRoLoG Consensus Initiative (Part 2—Technical)
      Application of the Lugano Classification for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The PRoLoG Consensus Initiative (Part 2—Technical)
      Fabien Ricard, Sally Barrington, Ron Korn, Guenther Brueggenwerth, Judith Trotman, Bruce Cheson, Gilles Salles, Larry Schwartz, Greg Goldmacher, Rudresh Jarecha, Jayant Narang, Florence Broussais, Paul Galette, Min Liu, Surabhi Bajpai, Eric Perlman, Julie Gillis, Ira Smalberg, Pierre Terve, Gudrun Zahlmann and Annette Schmid
      Journal of Nuclear Medicine February 1, 2023, 64 (2) 239-243; DOI: https://doi.org/10.2967/jnumed.122.264124

  3. Bal, Chandrasekhar

    1. Survival Outcomes in Metastatic Gastroenteropancreatic Neuroendocrine Tumor Patients Receiving Concomitant <sup>225</sup>Ac-DOTATATE–Targeted α-Therapy and Capecitabine: A Real-World-Scenario Management-Based Long-Term Outcome Study
      Survival Outcomes in Metastatic Gastroenteropancreatic Neuroendocrine Tumor Patients Receiving Concomitant 225Ac-DOTATATE–Targeted α-Therapy and Capecitabine: A Real-World-Scenario Management-Based Long-Term Outcome Study
      Sanjana Ballal, Madhav P. Yadav, Madhavi Tripathi, Ranjit Kumar Sahoo and Chandrasekhar Bal
      Journal of Nuclear Medicine February 1, 2023, 64 (2) 211-218; DOI: https://doi.org/10.2967/jnumed.122.264043

  4. Ballal, Sanjana

    1. Survival Outcomes in Metastatic Gastroenteropancreatic Neuroendocrine Tumor Patients Receiving Concomitant <sup>225</sup>Ac-DOTATATE–Targeted α-Therapy and Capecitabine: A Real-World-Scenario Management-Based Long-Term Outcome Study
      Survival Outcomes in Metastatic Gastroenteropancreatic Neuroendocrine Tumor Patients Receiving Concomitant 225Ac-DOTATATE–Targeted α-Therapy and Capecitabine: A Real-World-Scenario Management-Based Long-Term Outcome Study
      Sanjana Ballal, Madhav P. Yadav, Madhavi Tripathi, Ranjit Kumar Sahoo and Chandrasekhar Bal
      Journal of Nuclear Medicine February 1, 2023, 64 (2) 211-218; DOI: https://doi.org/10.2967/jnumed.122.264043

  5. Baltzer, Pascal

    1. Clinical Decision Support for Axillary Lymph Node Staging in Newly Diagnosed Breast Cancer Patients Based on <sup>18</sup>F-FDG PET/MRI and Machine Learning
      Clinical Decision Support for Axillary Lymph Node Staging in Newly Diagnosed Breast Cancer Patients Based on 18F-FDG PET/MRI and Machine Learning
      Janna Morawitz, Benjamin Sigl, Christian Rubbert, Nils-Martin Bruckmann, Frederic Dietzel, Lena J. Häberle, Saskia Ting, Svjetlana Mohrmann, Eugen Ruckhäberle, Ann-Kathrin Bittner, Oliver Hoffmann, Pascal Baltzer, Panagiotis Kapetas, Thomas Helbich, Paola Clauser, Wolfgang P. Fendler, Christoph Rischpler, Ken Herrmann, Benedikt M. Schaarschmidt, Andreas Stang, Lale Umutlu, Gerald Antoch, Julian Caspers and Julian Kirchner
      Journal of Nuclear Medicine February 1, 2023, 64 (2) 304-311; DOI: https://doi.org/10.2967/jnumed.122.264138

  6. Barrington, Sally

    1. Application of the Lugano Classification for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The PRoLoG Consensus Initiative (Part 2—Technical)
      Application of the Lugano Classification for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The PRoLoG Consensus Initiative (Part 2—Technical)
      Fabien Ricard, Sally Barrington, Ron Korn, Guenther Brueggenwerth, Judith Trotman, Bruce Cheson, Gilles Salles, Larry Schwartz, Greg Goldmacher, Rudresh Jarecha, Jayant Narang, Florence Broussais, Paul Galette, Min Liu, Surabhi Bajpai, Eric Perlman, Julie Gillis, Ira Smalberg, Pierre Terve, Gudrun Zahlmann and Annette Schmid
      Journal of Nuclear Medicine February 1, 2023, 64 (2) 239-243; DOI: https://doi.org/10.2967/jnumed.122.264124

  7. Bassett, Paul

    1. Eligibility for <sup>177</sup>Lu-PSMA Therapy Depends on the Choice of Companion Diagnostic Tracer: A Comparison of <sup>68</sup>Ga-PSMA-11 and <sup>99m</sup>Tc-MIP-1404 in Metastatic Castration-Resistant Prostate Cancer
      Open Access
      Eligibility for 177Lu-PSMA Therapy Depends on the Choice of Companion Diagnostic Tracer: A Comparison of 68Ga-PSMA-11 and 99mTc-MIP-1404 in Metastatic Castration-Resistant Prostate Cancer
      Gary J.R. Cook, Wai-Lup Wong, Bal Sanghera, Stephen Mangar, Amarnath Challapalli, Amit Bahl, Paul Bassett, Darren Leaning and Christian Schmidkonz
      Journal of Nuclear Medicine February 1, 2023, 64 (2) 227-231; DOI: https://doi.org/10.2967/jnumed.122.264296

  8. Beaudoin, Jean-François

    1. <sup>68</sup>Ga-DOTATATE Prepared from Cyclotron-Produced <sup>68</sup>Ga: An Integrated Solution from Cyclotron Vault to Safety Assessment and Diagnostic Efficacy in Neuroendocrine Cancer Patients
      Open Access
      68Ga-DOTATATE Prepared from Cyclotron-Produced 68Ga: An Integrated Solution from Cyclotron Vault to Safety Assessment and Diagnostic Efficacy in Neuroendocrine Cancer Patients
      Sébastien Tremblay, Jean-François Beaudoin, Ophélie Bélissant Benesty, Samia Ait-Mohand, Véronique Dumulon-Perreault, Étienne Rousseau, Éric E. Turcotte and Brigitte Guérin
      Journal of Nuclear Medicine February 1, 2023, 64 (2) 232-238; DOI: https://doi.org/10.2967/jnumed.121.263768

  9. Belissant Benesty, Ophélie

    1. <sup>68</sup>Ga-DOTATATE Prepared from Cyclotron-Produced <sup>68</sup>Ga: An Integrated Solution from Cyclotron Vault to Safety Assessment and Diagnostic Efficacy in Neuroendocrine Cancer Patients
      Open Access
      68Ga-DOTATATE Prepared from Cyclotron-Produced 68Ga: An Integrated Solution from Cyclotron Vault to Safety Assessment and Diagnostic Efficacy in Neuroendocrine Cancer Patients
      Sébastien Tremblay, Jean-François Beaudoin, Ophélie Bélissant Benesty, Samia Ait-Mohand, Véronique Dumulon-Perreault, Étienne Rousseau, Éric E. Turcotte and Brigitte Guérin
      Journal of Nuclear Medicine February 1, 2023, 64 (2) 232-238; DOI: https://doi.org/10.2967/jnumed.121.263768

  10. Benzinger, Tammie L.S.

    1. The RSNA QIBA Profile for Amyloid PET as an Imaging Biomarker for Cerebral Amyloid Quantification
      Anne M. Smith, Nancy A. Obuchowski, Norman L. Foster, Gregory Klein, P. David Mozley, Adriaan A. Lammertsma, Richard L. Wahl, John J. Sunderland, Jean-Luc Vanderheyden, Tammie L.S. Benzinger, Paul E. Kinahan, Dean F. Wong, Eric S. Perlman, Satoshi Minoshima and Dawn Matthews
      Journal of Nuclear Medicine February 1, 2023, 64 (2) 294-303; DOI: https://doi.org/10.2967/jnumed.122.264031
    2. Investigating Tau and Amyloid Tracer Skull Binding in Studies of Alzheimer Disease
      Investigating Tau and Amyloid Tracer Skull Binding in Studies of Alzheimer Disease
      Shaney Flores, Charles D. Chen, Yi Su, Aylin Dincer, Sarah J. Keefe, Nicole S. McKay, Angela M. Paulick, Gloria Guzman Perez-Carrillo, Liang Wang, Russ C. Hornbeck, Manu Goyal, Andrei Vlassenko, Sally Schwarz, Michael L. Nickels, Dean F. Wong, Zhude Tu, Jonathan E. McConathy, John C. Morris, Tammie L.S. Benzinger and Brian A. Gordon
      Journal of Nuclear Medicine February 1, 2023, 64 (2) 287-293; DOI: https://doi.org/10.2967/jnumed.122.263948
« Previous (Pages : 1 2 3 4 5 6 7 ... 27) Next »
Back to top

In this issue